BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 33169637)

  • 1. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
    Cure E; Cumhur Cure M; Vatansev H
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
    Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
    mBio; 2020 May; 11(3):. PubMed ID: 32444383
    [No Abstract]   [Full Text] [Related]  

  • 4. ACE2 and COVID-19 and the resulting ARDS.
    Zhang X; Li S; Niu S
    Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.
    Silva-Aguiar RP; Peruchetti DB; Rocco PRM; Schmaier AH; E Silva PMR; Martins MA; Carvalho VF; Pinheiro AAS; Caruso-Neves C
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L596-L602. PubMed ID: 32783619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system and COVID-19 infection.
    Alexandre J; Cracowski JL; Richard V; Bouhanick B;
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can beta-adrenergic blockers be used in the treatment of COVID-19?
    Vasanthakumar N
    Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480
    [No Abstract]   [Full Text] [Related]  

  • 11. [Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection:friend or foe?].
    Yang JM; Meng X; Xue F; Zhang Y; Zhang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):527-531. PubMed ID: 32189489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].
    Shi HZ; Ma P; Gao FY; Chen GL; Wang YH; Xian XD; Dong ED
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):532-538. PubMed ID: 32166940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19.
    Yang S; Meng G
    J Mol Cell Cardiol; 2020 Apr; 141():110-111. PubMed ID: 32272142
    [No Abstract]   [Full Text] [Related]  

  • 14. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
    Huang Y; Xie C; Chen X; Hong Q; Huang H
    Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19.
    Gue YX; Kanji R; Markides V; Gorog DA
    Am J Cardiol; 2020 Sep; 130():161-162. PubMed ID: 32636018
    [No Abstract]   [Full Text] [Related]  

  • 16. Covid-19: the renin-angiotensin system imbalance hypothesis.
    Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
    Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute Respiratory Distress Syndrome.
    Haudebourg AF; Perier F; Tuffet S; de Prost N; Razazi K; Mekontso Dessap A; Carteaux G
    Am J Respir Crit Care Med; 2020 Jul; 202(2):287-290. PubMed ID: 32479162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
    Cano F; Gajardo M; Freundlich M
    Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
    Silhol F; Sarlon G; Deharo JC; Vaïsse B
    Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
    [No Abstract]   [Full Text] [Related]  

  • 20. [The RAAS and SARS-CoV-2: A riddle to solve].
    Choi M; Aiello EA; Ennis IL; Villa-Abrille MC
    Hipertens Riesgo Vasc; 2020; 37(4):169-175. PubMed ID: 32527699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.